PT94030A - PROCESS OF PREPARATION OF ANTIGEN PROTECTIVE AGAINST BORDETELLA INFECTIONS AND TOXIC EFFECTS - Google Patents

PROCESS OF PREPARATION OF ANTIGEN PROTECTIVE AGAINST BORDETELLA INFECTIONS AND TOXIC EFFECTS

Info

Publication number
PT94030A
PT94030A PT94030A PT9403090A PT94030A PT 94030 A PT94030 A PT 94030A PT 94030 A PT94030 A PT 94030A PT 9403090 A PT9403090 A PT 9403090A PT 94030 A PT94030 A PT 94030A
Authority
PT
Portugal
Prior art keywords
preparation
toxic effects
protective against
against bordetella
antigen protective
Prior art date
Application number
PT94030A
Other languages
Portuguese (pt)
Other versions
PT94030B (en
Inventor
Nicole Guiso-Maclouf
Original Assignee
Pasteur Institut
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pasteur Institut filed Critical Pasteur Institut
Publication of PT94030A publication Critical patent/PT94030A/en
Publication of PT94030B publication Critical patent/PT94030B/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/099—Bordetella
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/235—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Bordetella (G)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/88—Lyases (4.)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
    • A61K2039/521—Bacterial cells; Fungal cells; Protozoal cells inactivated (killed)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies

Abstract

The invention relates to a method of immunizing a mammal against infection by a first Bordetella species. The method comprises administering to the mammal a preparation comprising a portion of the amino acid sequence of mature adenylate cyclase of a second Bordetella species. The invention also relates to vaccine preparations comprising a portion of the amino acid sequence of mature adenylate cyclase from Bordetella species.
PT94030A 1989-05-12 1990-05-14 PROCESS OF PREPARATION OF ANTIGEN PROTECTIVE AGAINST BORDETELLA INFECTIONS AND TOXIC EFFECTS PT94030B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR8906321A FR2646776B1 (en) 1989-05-12 1989-05-12 USE OF VACCINANT PREPARATIONS BASED ON ADENYL CYCLASE OR OF BACTERIA PRODUCING THEM AS PROTECTIVE ANTIGENS AGAINST THE EFFECTS OF BORDETELLA

Publications (2)

Publication Number Publication Date
PT94030A true PT94030A (en) 1991-01-08
PT94030B PT94030B (en) 1997-07-31

Family

ID=9381646

Family Applications (1)

Application Number Title Priority Date Filing Date
PT94030A PT94030B (en) 1989-05-12 1990-05-14 PROCESS OF PREPARATION OF ANTIGEN PROTECTIVE AGAINST BORDETELLA INFECTIONS AND TOXIC EFFECTS

Country Status (10)

Country Link
US (3) US6214356B1 (en)
EP (1) EP0424518B1 (en)
JP (1) JP3399525B2 (en)
AT (1) ATE115861T1 (en)
CA (1) CA2033085C (en)
DE (1) DE69015314T2 (en)
ES (1) ES2066206T3 (en)
FR (1) FR2646776B1 (en)
PT (1) PT94030B (en)
WO (1) WO1990013312A1 (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2646776B1 (en) 1989-05-12 1994-06-03 Pasteur Institut USE OF VACCINANT PREPARATIONS BASED ON ADENYL CYCLASE OR OF BACTERIA PRODUCING THEM AS PROTECTIVE ANTIGENS AGAINST THE EFFECTS OF BORDETELLA
FR2728170A1 (en) * 1994-12-15 1996-06-21 Pasteur Institut ANTI-BORDETELLA CELL-LIKE VACCINE
US6030625A (en) * 1994-12-15 2000-02-29 Institut Pasteur Bordetella pertussis and Bordetella parapertussis strains
FR2736064B1 (en) 1995-06-30 1997-09-05 Pasteur Institut PROTECTIVE EPITOPES OF ADENYL CYCLASE-HEMOLYSIN (AC-HTY). THEIR APPLICATION TO THE TREATMENT OR PREVENTION OF BORDETELLA INFECTIONS
US7462472B2 (en) * 2001-11-02 2008-12-09 The University Of Chicago Methods and compositions relating to anthrax pathogenesis
WO2005032584A2 (en) 2003-10-02 2005-04-14 Glaxosmithkline Biologicals S.A. Pertussis antigens and use thereof in vaccination
US7521059B2 (en) * 2004-06-14 2009-04-21 Fenwick Bradley W Kennel cough vaccine

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8412207D0 (en) * 1984-05-12 1984-06-20 Wellcome Found Antigenic preparations
US5237052A (en) 1984-05-12 1993-08-17 Burroughs Wellcome Company Antigenic preparations and isolation of such preparations
US4652521A (en) * 1985-03-04 1987-03-24 Regents Of The University Of Minnesota Method for the early diagnosis of bordetella diseases and kit therefor
FR2590483B1 (en) * 1985-11-22 1988-12-09 Pasteur Institut PURIFIED ANTIGENS HAVING VACCINATION PROPERTIES AGAINST B. PERTUSSIS, IN PARTICULAR RECOMBINANT DNA MEANS, AND VACCINE COMPOSITIONS CONTAINING THEM
FR2606789B1 (en) * 1986-11-17 1991-05-31 Pasteur Institut PURIFIED ADENYLATE CYCLASE PREPARATIONS, PROCESS FOR OBTAINING SUCH PREPARATIONS AND THEIR BIOLOGICAL APPLICATIONS
EP0267998A1 (en) * 1986-11-17 1988-05-25 Institut Pasteur Means for protecting against bordetella infections and toxic processes
FR2621597B1 (en) 1987-07-24 1992-07-31 Pasteur Institut METHOD FOR CLONING AND EXPRESSING GENES ENCODING PROTEINS CONSTITUTING ORGANIZED FUNCTIONAL BUILDINGS
ATE140729T1 (en) * 1988-04-19 1996-08-15 Pasteur Institut METHOD FOR OBTAINING PROTECTIVE ANTIGENS AGAINST BORDETELLA INFECTIONS AND TOXIC PROCESSES
EP0338170A1 (en) * 1988-04-19 1989-10-25 Institut Pasteur Immunoprotective antigenic protein against pathogenic bacteria
FR2638169B1 (en) * 1988-10-25 1991-01-11 Pasteur Institut ADENYL CYCLASE DERIVATIVES AND THEIR BIOLOGICAL USES
FR2646776B1 (en) * 1989-05-12 1994-06-03 Pasteur Institut USE OF VACCINANT PREPARATIONS BASED ON ADENYL CYCLASE OR OF BACTERIA PRODUCING THEM AS PROTECTIVE ANTIGENS AGAINST THE EFFECTS OF BORDETELLA
ATE121754T1 (en) * 1989-09-04 1995-05-15 Wellcome Found VACCINE AGAINST BORDETELLA.
US5786189A (en) * 1989-11-29 1998-07-28 Smithkline Beecham Biologicals (S.A.) Vaccine
HU219819B (en) * 1992-08-18 2001-08-28 Dimminaco Ag/Sa/Ltd. Isolated polinucleotide, bordetella bronchiseptica strain containing them, and bordetella bronchiseptica vaccine
US6030625A (en) * 1994-12-15 2000-02-29 Institut Pasteur Bordetella pertussis and Bordetella parapertussis strains
FR2728170A1 (en) * 1994-12-15 1996-06-21 Pasteur Institut ANTI-BORDETELLA CELL-LIKE VACCINE
EP1233022B1 (en) * 1995-05-04 2015-12-09 Aventis Pasteur Limited Methods of preparation of components of acellular pertussis vaccines
FR2736064B1 (en) * 1995-06-30 1997-09-05 Pasteur Institut PROTECTIVE EPITOPES OF ADENYL CYCLASE-HEMOLYSIN (AC-HTY). THEIR APPLICATION TO THE TREATMENT OR PREVENTION OF BORDETELLA INFECTIONS
GB9718901D0 (en) * 1997-09-05 1997-11-12 Smithkline Beecham Biolog Vaccine
ES2303833T3 (en) * 2000-05-25 2008-09-01 Institut Pasteur POLYPEPTIDES CONTAINING POLYMORPHISMS OF THE REPEATED REGIONS OF PERTACTIN IN BORDETELLA PERTUSSIS, BORDETELLA PARAPERTUSSIS AND BORDETELLA BRONCHISEPTICA, ITS USE IN DIAGNOSIS AND IN IMMUNOGENIC COMPOSITIONS.
EP1188446B1 (en) 2000-09-15 2009-08-05 Institut Pasteur Proteinaceous vectors for molecule delivery to CD11b expressing cells

Also Published As

Publication number Publication date
US20030224003A1 (en) 2003-12-04
US6214356B1 (en) 2001-04-10
JPH03506044A (en) 1991-12-26
CA2033085A1 (en) 1990-11-13
US7211263B2 (en) 2007-05-01
JP3399525B2 (en) 2003-04-21
CA2033085C (en) 2003-07-22
ATE115861T1 (en) 1995-01-15
EP0424518A1 (en) 1991-05-02
WO1990013312A1 (en) 1990-11-15
PT94030B (en) 1997-07-31
FR2646776B1 (en) 1994-06-03
DE69015314D1 (en) 1995-02-02
FR2646776A1 (en) 1990-11-16
ES2066206T3 (en) 1995-03-01
EP0424518B1 (en) 1994-12-21
US20020172691A1 (en) 2002-11-21
DE69015314T2 (en) 1996-11-28

Similar Documents

Publication Publication Date Title
DK0754055T3 (en) Group A streptococcal polysaccharide immunogen preparations and methods
PL304419A1 (en) Urease based vaccine against heliobacter infections
MX9301706A (en) VACCINE COMPOSITION FOR THE TREATMENT OF HELICOBACTER INFECTION.
ATE430200T1 (en) VACCINE AGAINST THE VIRUS RESPONSIBLE FOR RESPIRATORY AND REPRODUCTIVE DISEASES IN SWINE
ATE127345T1 (en) STRESS PROTEINS AND USES THEREOF.
ES2100240T3 (en) BACTERIOPHAGUS MODIFIED BY GENETIC ENGINEERING AND VACCINES THAT CONTAIN THEM.
NO950483L (en) Hepatitis A vaccine
PT94030A (en) PROCESS OF PREPARATION OF ANTIGEN PROTECTIVE AGAINST BORDETELLA INFECTIONS AND TOXIC EFFECTS
CA2217522A1 (en) Isolated frpb nucleic acid molecule and vaccine
WO1994010317A3 (en) Conjugate vaccine against group b streptococcus
ES2084576T3 (en) VACCINE AGAINST COCCIDIOSIS.
EP0161095A3 (en) Vaccine against urinary infection
WO2002092131A3 (en) Immunogenic conjugates of low molecular weight hyaluronic acid with polypeptide toxins
PT99923A (en) METHOD FOR PREPARING HIBRID PROTEINS OF PLASMODIUM FALCIPARUM CONTAINING SEQUENCES OF ANTIGENES OF HRPII AND SERP MALARIA AND OF PHARMACEUTICAL COMPOSITIONS CONTAINING THESE PROTEINS
Panse et al. Passive immunity in experimental cholera
ATE111485T1 (en) PEPTIDE TREATMENT OF PERSISTENT INFECTIOUS DISEASES.
Puentes et al. Efficacy of Various Non‐Oily Adjuvants in Immunization Against the Aujeszky's Disease (Pseudorabies) Virus
ATE439857T1 (en) LIPOGLYCAN COMPOSITIONS AND METHODS FOR TREATING PARASITIC INFECTIONS
PL341541A1 (en) Isolated strains of staphyloccoccus aureus and vaccines prepared of them
NO934547L (en) Oral treatment of Helicobacter infection
MY104932A (en) Immunomodulatory azaspiranes

Legal Events

Date Code Title Description
FG3A Patent granted, date of granting

Effective date: 19970506

MM4A Annulment/lapse due to non-payment of fees, searched and examined patent

Free format text: MAXIMUM VALIDITY LIMIT REACHED

Effective date: 20120507